| Specimen Type | Specimen Stability | Reference Range |
| Liquid Based Pap sample | 21 calendar days, Room Temp | Not Detected |
Specimen Requirements
Cervical sample from the junction of the ectocervix and the endocervix (transition zone) in Surepath Liquid-Based Pap Test Preservative fluid OR Thinprep Pap Test PreservCyt® fluid.
|
Method
Target Capture, TMA: Transcription-Mediated Amplification (NAT) and Dual Kinetic Assay (DKA). All specimens testing positive in the screening assay are confirmed in a confirmatory assay targeting different regions of the nucleic acid of the organism. This assay has been cleared for use by the FDA on some specimen types. For other specimen types where this assay has not been cleared or approved by the FDA; Pathology, Inc. has validated this test and determined its performance characteristics. This individual validation has not been cleared nor approved by the FDA.
|
Schedule
Mon-Sat
|
Turn-Around Time
24-48 hrs
|
Instructions/Notes
See Appendix, Gynecologic Cytopathology Specimen Collection
|
Clinical Utility
To detect chlamydia and/or gonorrhea infection.
|
CPT Codes
87491;87591
|
Related Materials |